MARKET RADAR
SENSEX     NIFTY      Refresh
Hester Biosciences Nine Months, Hester Biosciences Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Hester Biosciences
Hester Biosciences
BSE: 524669|ISIN: INE782E01017|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 17, 17:00
107.75
-1.6 (-1.46%)
VOLUME 308
Hester Biosciences is not listed on NSE
Download Annual Report PDF Format 2011 | 2010

Nine Months of Hester Biosciences

------------------- in Rs. Cr. -------------------
Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Net Sales/Income from operations 46.57 34.55 31.96 27.73 22.10
Other Operating Income 1.51 0.25 -- -- --
Total Income From Operations 48.08 34.80 31.96 -- --
EXPENDITURE
Consumption of Raw Materials 11.96 8.39 8.13 6.36 5.79
Purchase of Traded Goods 1.74 0.35 -- -- --
Increase/Decrease in Stocks -3.35 -5.44 -3.15 -2.87 -4.13
Power & Fuel -- -- -- -- --
Employees Cost 6.48 5.00 4.31 3.61 2.62
Depreciation 3.07 3.09 3.02 2.77 2.87
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 6.31 4.38 4.30 3.42 --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 6.89 6.31 4.50 4.64 6.40
P/L Before Other Inc. , Int., Excpt. Items & Tax 14.99 12.72 10.85 -- --
Other Income 0.06 0.08 0.06 0.02 0.00
P/L Before Int., Excpt. Items & Tax 15.05 12.79 10.91 -- --
Interest 2.31 2.20 1.85 1.79 2.21
P/L Before Exceptional Items & Tax 12.74 10.59 9.06 -- --
Exceptional Items -- 0.04 -- -- --
P/L Before Tax 12.74 10.64 9.06 -- --
Tax 5.52 3.27 3.01 2.73 2.18
P/L After Tax from Ordinary Activities 7.22 7.37 6.05 -- --
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 7.22 7.37 6.05 5.31 4.16
Equity Share Capital 8.51 5.19 5.19 5.19 5.19
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 8.48 14.19 11.66 -- --
Diluted EPS 8.48 14.19 11.66 -- --
EPS After Extra Ordinary
Basic EPS 8.48 14.19 11.66 -- --
Diluted EPS 8.48 14.19 11.66 -- --
Public Share Holding
No Of Shares (Crores) 0.40 0.26 0.26 0.26 0.27
Share Holding (%) 46.51 49.30 49.25 49.25 52.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 0.46 0.26 0.26 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 53.49 50.70 50.75 -- --
Notes
Source : Dion Global Solutions Limited
Quick Links for hesterbiosciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.